Table 2.
Characteristics and outcomes of pericentric inversion chromosome 9 group and control group
| Group 1 (n = 107) | Group 2 (n = 107) | p | |
|---|---|---|---|
| Female age (years) | 33.00 | 32.00 | .526 |
| Male age (years) | 33.00 | 34.00 | .000* |
| Female BMI | 21.90 | 21.60 | .733 |
| Basic FSH (IU/L) | 7.33 | 7.93 | .001* |
| Primary/secondary infertility | 73/34 | 53/54 |
.005* OR 2.188 95% CI [1.254, 3.815 |
| IVF/ICSI | 85/22 | 74/33 | .085 |
| Protocol | .433 | ||
| Oocyte | 13.00 | 14.00 | .056 |
| Total oocyte | 1,128 | 1,041 | |
| Normal Fertilization rate (%) | 753/1128 (66.76%) | 663/1041 (63.69%) | .134 |
| Abnormal Fertilization rate (%) | 87/840 (10.36%) | 72/735 (9.8%) | .712 |
| Cleavage rate (%) | 800/840 (95.24%) | 670/735 (91.16%) |
.001* OR 1.940 95% CI [1.292, 2.915] |
| Utilization rate (%) | 509/800 (63.63%) | 394/670 (58.81%) | .059 |
| Total number of embryo transferred | 144 | 144 | |
| Patients with transfer (%) | 75/107 (70.09%) | 76/107 (71.03%) | .881 |
| Clinical pregnancy rate (%) | 32/75 (42.67%) | 32/76 (42.11%) | .944 |
| Implantation rate (%) | 44/144 (30.56%) | 43/144 (29.86%) | .898 |
| Live birth rate per embryo transfer (%) | 29/75 (38.67%) | 28/76 (36.84%) | .817 |
| Miscarriage rate (%) | 3/32 (9.38%) | 4/32 (12.50%) | .688a |
Group 1 = pericentric inversion chromosome 9 group, Group 2 = control group.
Abbreviations: BMI, body mass index; FSH, follicle stimulating hormone.
a
Fisher's exact test was used.
*
p < .05, the difference was considered statistically significant.